Skeletal muscle disorders are dramatically increasing with human aging with enormous sanitary costs and impact on the quality of life. Preventive and therapeutic tools to limit onset and progression of muscle frailty include nutrition and physical training. Melatonin, the indole produced at nighttime in pineal and extra-pineal sites in mammalians, has recognized anti-aging, anti-inflammatory, and anti-oxidant properties. Mitochondria are the favorite target of melatonin, which maintains them efficiently, scavenging free radicals and reducing oxidative damage. Here, we discuss the most recent evidence of dietary melatonin efficacy in age-related skeletal muscle disorders in cellular, preclinical, and clinical studies. Furthermore, we analyze the emerging impact of melatonin on physical activity. Finally, we consider the newest evidence of the gut-muscle axis and the influence of exercise and probably melatonin on the microbiota. In our opinion, this review reinforces the relevance of melatonin as a safe nutraceutical that limits skeletal muscle frailty and prolongs physical performance.
Keywords: aging; fibromyalgia; melatonin; mitochondria; mitophagy; physical training; rodents; sarcopenia.
Conflict of interest statement
“The authors declare no conflict of interest.”
Aging Gut Microbiota at the Cross-Road between Nutrition, Physical Frailty, and Sarcopenia: Is There a Gut-Muscle Axis?Nutrients. 2017 Nov 30;9(12):1303. doi: 10.3390/nu9121303. Nutrients. 2017. PMID: 29189738 Free PMC article. Review.
Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia.Nutrients. 2019 Jul 17;11(7):1633. doi: 10.3390/nu11071633. Nutrients. 2019. PMID: 31319564 Free PMC article. Review.
Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT).J Physiol Pharmacol. 2007 Sep;58(3):381-405. J Physiol Pharmacol. 2007. PMID: 17928638 Review.
Adaptations of the aging animal to exercise: role of daily supplementation with melatonin.J Pineal Res. 2013 Oct;55(3):229-39. doi: 10.1111/jpi.12065. Epub 2013 May 28. J Pineal Res. 2013. PMID: 23711171
Melatonin as a Potential Agent in the Treatment of Sarcopenia.Int J Mol Sci. 2016 Oct 24;17(10):1771. doi: 10.3390/ijms17101771. Int J Mol Sci. 2016. PMID: 27783055 Free PMC article. Review.